Gene and protein study of blood cells in inflammatory blood diseases
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study looks at blood cells from people with certain blood conditions who also have fevers with no clear cause. It aims to understand the genetic and functional features of these cells, which may help explain why fever and inflammation happen. You will likely have a blood sample taken for testing, and the results may inform future treatments, though the study itself does not test a new treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older and able to give your own consent.
- You must have one of these blood conditions: myelodysplastic syndrome (a bone marrow problem), multiple myeloma (a blood cancer), MGUS (a pre-cancerous blood condition), or Schnitzler's syndrome (a rare inflammatory disease).
- You must have a fever with no known cause, along with one of these symptoms: rash, joint pain or swelling, inflammation around your heart or lungs, or belly pain.
- You must be able to speak French and answer questions for the study.
- Your symptoms must not already be explained by another illness.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with early, “precursor” blood conditions to learn what changes in their blood or bone marrow signal progression. It may help doctors better predict outcomes and understand why some people develop symptom-causing cancer.
This study looks at how your gut bacteria (intestinal flora) and immune system relate to a condition called monoclonal gammopathy, where an abnormal protein is found in the blood. The trial will check samples from your blood, plasma, and stool to understand these connections.
This trial studies myeloma (and closely related blood disorders) by using extra blood or bone marrow samples for lab research. It aims to help discover new ways to understand or treat myeloma.
This is an observational study that follows people with early blood findings that can be linked to multiple myeloma, to understand what happens over time. It does not test a new drug for most people; instead, it tracks health, lab results, and imaging to learn who may develop myeloma.
This study looks at blood “biomarkers,” or measurable body signals, in people with autoimmune diseases, vasculitis, or autoinflammatory conditions. The goal is to better understand these illnesses and how they relate to disease activity.
This study looks at bone marrow stem cells in people with Waldenström macroglobulinemia (WM). It aims to understand how these cells work and may help improve future treatments for WM.
Hear when a new Monoclonal Gammopathy of Undetermined Significance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.